• Contact Us
  • Submit RFI/RFP
  • Trust Center
  • Ethics Hotline (report a violation)
  • LIFE SCIENCES
  • HEALTHCARE
  • RESOURCES
    • The Future Prescription
    • Blog
    • Case Studies & Publications
    • Events
    • Press Releases
  • ABOUT
    • Leadership
    • Board of Directors
    • Our Vision and Mission
    • Careers
    • Locations
  • SIGN IN
    • TriNetX LIVE™
    • EVIDEX®
  • Trial Design
  • Datasets & Analytics
  • Non-US Oncology
  • RWE Generation
  • Drug Safety

Allergan Joins TriNetX to Access Network of Real-World Data for Clinical Research

Oct 10, 2018 | Press Releases

Cambridge, MA, October 10, 2018 — Allergan, a leading global pharmaceutical company, has joined the TriNetX global health research network for real-time access to patient populations, driven and refreshed by clinical data, to determine protocol feasibility, cohort...

TriNetX Unveils Self-Service Precision Medicine Analytics for the Research Community

Sep 25, 2018 | Press Releases

Global Network of Researchers Arrive in Boston to Collaborate and Discuss R&D at TriNetX Summit Cambridge, MA, September 25, 2018 — TriNetX, the global health research network that optimizes clinical research and enables discoveries through the creation of...

Hadassah Medical Center Joins TriNetX to Increase Clinical Trial Collaboration Efforts with Pharma

Jul 31, 2018 | Press Releases

Cambridge, MA, July 31, 2018 — Hadassah Medical Center, a leading healing, teaching, and research hospital in Jerusalem, Israel, is the first medical center in the country to join the TriNetX global health research network to increase clinical trial activity and help...

Carilion Clinic Joins TriNetX Network to Expand Clinical Research and Collaboration Opportunities

Jul 25, 2018 | Press Releases

Cambridge, MA, July 25, 2018 — Carilion Clinic, a not-for-profit healthcare organization serving nearly one million residents in western Virginia, has joined the TriNetX global health research network to better assess its patient population for the feasibility of...

Cardiovascular Research Consortium to Provide Access to Real-World Heart Care Data via the TriNetX Platform

Jun 12, 2018 | Press Releases

Cambridge, MA, June 12, 2018 — The Cardiovascular Research Consortium (CRC), a nationwide network of community-based cardiology practices, has selected TriNetX’s real-world evidence platform to provide the biopharmaceutical industry with the first-of-its-kind access...

Tartu University Hospital Expanding Clinical Trial Capabilities Internationally with TriNetX

Jun 4, 2018 | Press Releases

Tallinn, ESTONIA, 4 June, 2018 — Tartu University Hospital, the only university hospital in Estonia and an e-Health pioneer, has joined the TriNetX global health research network, in an effort to grow its clinical trial participation internationally. TriNetX’s rapidly...

TriNetX Unveils State-of-the-Art Analytics Solutions for Use with Its Clinical Data

May 21, 2018 | Press Releases

Enables Researchers to Hypothesize and Answer Complex Research Questions About Patient Outcomes & Treatment Effectiveness  BALTIMORE, MD – ISPOR 2018 – May 21, 2018 – TriNetX™, the global health research network, today announced the availability of TriNetX...

ISPOR 2018 – “Using Real World Data to Establish an Optimal Treatment Target for Hba1c in Diabetes Type 2”

May 19, 2018 | Events, Published Research

Presented at ISPOR 2018, this poster investigates using real world data to establish an optimal treatment target for Hba1c in diabetes type 2. Stapff MP, Palm S, Stacey J TriNetX Inc., Cambridge, MA, USA ISPOR 2018 Download the poster...

ISPOR 2018 – “A Real-World Data Analysis Evaluating the Time to Glycemic Control After Initiation of Basal Insulin in Type 2 Diabetic Patients”

May 19, 2018 | Events, Published Research

Presented at ISPOR 2018, this poster is a real-world data analysis evaluating the time to glycemic control after initiation of basal insulin in type 2 diabetic patients. Stacey J, Hilderbrand S, Stapff MP TriNetX Inc., Cambridge, MA, USA ISPOR 2018 Download the poster...

ISPOR 2018 – “Comparison of Bleeding Events, Strokes, and Myocardial Infarcts on Warfarin or Dabigatran for Treatment of Atrial Fibrillation: Results of a Real-World Data Analysis”

May 19, 2018 | Events, Published Research

Presented at ISPOR 2018, this poster is a comparison of bleeding events, strokes, and myocardial infarcts on warfarin or dabigatran for treatment of atrial fibrillation: results of a real-world data analysis. Stapff MP TriNetX Inc., Cambridge, MA, USA ISPOR 2018...
« Older Entries
Next Entries »

SOLUTIONS

Clinical Trial Design & Optimization

Data Sets & Analytics

Non-US Oncology

Insights & Evidence Generation

Drug Safety & Pharmacovigilance

WHO WE SERVE

Life Sciences

Healthcare Organizations

RESOURCES

Explore TriNetX RWD

Conferences

Webinars

Publications

Case Studies

ENTERPRISE

Leadership

Board of Directors

Careers

Locations

EMAIL OPT-IN

Get the latest on product updates, services, events, expert insights, and top industry trends.

Subscribe now

ABOUT TRINETX, LLC

TriNetX operates the world’s broadest federated network of real-world data in partnership with healthcare providers and applies intelligence that accelerates innovation across the healthcare ecosystem. Through its self-service, HIPAA-, GDPR-, and LGPD-compliant platform of federated deidentified and anonymous electronic health record datasets and consulting partnerships, TriNetX empowers its global community to improve clinical trial protocol design, streamline trial operations, refine safety signals, and enrich real-world evidence generation.

TriNetX, LLC complies with all applicable privacy laws. For more information please visit our Trust Center.

FOLLOW US

LinkedIn
© TriNetX, LLC All Rights Reserved.
Terms of Use
Privacy & Cookies
Do not sell or share my personal information